HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lin, W.-Y. Articles by Lan, J.-L. Search for Related Content PubMed PubMed Citation Articles by Lin, W.-Y. Articles by Lan, J.-L.

Technetium-99m-HMPAO Brain SPECT in Systemic Lupus Erythematosus with CNS Involvement

Departments of Nuclear Medicine and Internal Medicine, Taichung Veterans General Hospital, Taichung; National Yang-Ming University, Shih-Pai, Taipei, Taiwan

Correspondence: For correspondence or reprints contact: Wan-Yu Lin, MD, Department of Nuclear Medicine, Taichung Veterans General Hospital, No. 160, Sec. 3, Taichung Harbor Rd., Taichung 407, Taiwan.

ABSTRACT

Functional brain SPECT is playing an increasingly important role in evaluating CNS conditions in patients with systemic lupus erythematosus (SLE). However, SPECT findings varied in different studies because of their small population. Furthermore, earlier researchers, being restricted by the resolution of the camera, might not have been able to evaluate deep-seated nuclei such as the basal ganglia and thalamus. In this study, we describe the different patterns of SPECT findings in SLE patients with CNS involvement. Methods: Seventy-two SLE patients (aged 14–67 yr; mean 33.2 yr) were divided into three groups: Group 1 with definite neuro-psychiatric disorder (including stroke, seizures and psychosis); Group 2 with minor neuropsychiatric disorders (headache, dizziness and recent memory impairment); and Group 3 without any neuropsychiatrie symptoms or signs. Ninety minutes after injection of 1110 MBq ^99mTc-HMPAO, brain SPECT was performed using a dual-head camera and fan-beam collimator.In addition,MRI and an electroencephalography (EEG) were also performed. Results: SPECT findings were normal in 87% of the Group 3 patients and abnormal in all Group 1 patients; 84.6% of the Group 2 patients had abnormal SPECT findings. The parietal, frontal and temporal lobes were the most common areas of CNS involvement. Parietal lobes were involved in 95.6% of Group 1 patients and 80.7% in Group 2 patients. Frontal lobes were involved in 56.5% of Group 1 patients and 65.3% of Group 2 patients. Temporal lobes were involved in 56.5% of Group 1 patients and 46.1 % of Group 2 patients. The basal ganglion was involved in about 30% of Group 1 patients and 11.5% of Group 2 patients, while the thalamus and cerebellum were less involved in neuropsychiatrie SLE. MR images showed less sensitivity in the detection of CNS involvement than the SPECT and were normal in 27.3% of patients with definite neuropsychiatrie disorders. The EEG and anticardiolipin antibody did not correlate well to the clinical diagnosis. Conclusion: HMPAO brain SPECT had the best correlation with the clinical diagnosis and may provide additional and objective information on SLE patients with potential CNS involvement.

Key Words: systemic lupus erythematosus • central nervous system • technetium-99m-HMPAO • SPECT

This article has been cited by other articles:

				S. Appenzeller, B. J. Amorim, C. D. Ramos, P. A. Rio, E. C. S. de C. Etchebehere, E. E. Camargo, F. Cendes, and L. T. L. Costallat Voxel-based morphometry of brain SPECT can detect the presence of active central nervous system involvement in systemic lupus erythematosus Rheumatology, March 1, 2007; 46(3): 467 - 472. [Abstract] [Full Text] [PDF]

				M Govoni, G Castellino, M Padovan, M Borrelli, and F Trotta Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus Lupus, March 1, 2004; 13(3): 149 - 158. [Abstract] [PDF]

				F J Lopez-Longo, N Caro, M I Almoguera, J Olazaran, J C Alonso-Farto, A Ortega, I Monteagudo, C M. Gonzalez, and L Carreno Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage Lupus, November 1, 2003; 12(11): 813 - 819. [Abstract] [PDF]

				K. Oku, T. Atsumi, S. Furukawa, T. Horita, Y. Sakai, S. Jodo, Y. Amasaki, K. Ichikawa, O. Amengual, and T. Koike Cerebral imaging by magnetic resonance imaging and single photon emission computed tomography in systemic lupus erythematosus with central nervous system involvement Rheumatology, June 1, 2003; 42(6): 773 - 777. [Abstract] [Full Text] [PDF]

				G Sanna, M Piga, J W Terryberry, M T Peltz, S Giagheddu, L Satta, A Ahmed, A Cauli, C Montaldo, G Passiu, et al. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations Lupus, October 1, 2000; 9(8): 573 - 583. [Abstract] [PDF]

				S M Weiner, A Otte, M Schumacher, I Brink, F D Juengling, T Sobanksi, E U Nitzsche, and H H Peter Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus Lupus, June 1, 2000; 9(5): 386 - 389. [Abstract] [PDF]